Chemed (CHE) is down -10.1%, or -$56.39 to $502.97.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHE:
- Chemed price target lowered to $640 from $674 at RBC Capital
- Oppenheimer says Chemed should be down significantly on Vitas Florida Cap impact
- Chemed price target lowered to $650 from $708 at BofA
- Chemed’s Resilience Amid Challenges: Justifying a Buy Rating with Strong Long-Term Prospects
- Chemed Lowers Earnings Guidance for 2025